Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Personalised T Cell Activator Shows Promise
February 2026
A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.
Read more
4 Jul 2024
Immunoglobulin Replacement Therapy Reduces Infections in Patients with Haematological Malignancies
A recent study has found that immunoglobulin replacement therapy significantly decreases the incidence of infections and antimicrobial use in patients with chronic lymphocytic leukemia.
6
Mins
3 Jul 2024
EHA 2024 Interview: Saskia Middeldorp
I worked in a breast cancer laboratory at the National Cancer Institute (NCI), Bethesda, Maryland, USA, during the summer after my first…
29 Jun 2024
Comparing Quality of Life in Leukemia Treatments for Elderly Patients
A recent study reveals that older adults with acute myeloid leukaemia receiving hypomethylating agents enjoy significantly more home time compared to those on anthracycline-based therapy
29 Jun 2024
Key Drivers of Lung Injury in Paediatric Stem Cell Transplant Patients
A recent study has shed light on the complex interactions contributing to lung injury in paediatric patients undergoing hematopoietic cell transplantation.
28 Jun 2024
Novel Blood Biomarkers for Mortality Risk in General Population
Recent research has revealed that the red blood cell distribution width to albumin concentration ratio is associated with increased all-cause and cause-specific mortality.
27 Jun 2024
Watch EHA2024: Cold Agglutinin Disease in the Clinic
Watch this EHA2024 Satelite Symposium exploring the disease burden of CAD beyond anemia by examining its influence on day-to-day life and…
6
Mins
25 Jun 2024
EHA President 2024 Interview: Antonio Almeida
I think the most important thing to say in respect to this is that EHA is a members’ association, and as such, it’s crucial that we cater…
23 Jun 2024
Acalabrutinib and Chemotherapy Enhance Survival in Mantle Cell Lymphoma
Frontline treatment with acalabrutinib, bendamustine, and rituximab shows promising results in reducing disease progression and death in older mantle cell lymphoma patients.
Loading posts...
« Previous
1
…
43
44
45
46
47
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View